Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 0.79 — trading below book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -18.3%
cbdMD, INC. (YCBD) is a Basic Materials company operating in Perfumes, Cosmetics & Other Toilet Preparations, listed on the AMEX , with a market capitalisation of $7 million . Key value metrics: P/B ratio 0.79, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
cbdMD, INC. — Fundamental Analysis Summary
On financial health, YCBD shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -18.3% (sector average: -1.2%), and manageable leverage with a debt-to-equity ratio of 0.31.
StockPik's composite Value Score for YCBD is 70/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
YCBD reports a high gross margin of 62.6% (sector average: 12.8%) and a negative operating margin of -9.0%.
YCBD shows revenue declining at 1% year-over-year, with earnings growing at 45%.